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Running headline:  Mannans against Salmonella infection 
 
Abstract 
Aims 
To assess the efficacy of a β-galactomannan oligosaccharide (ß-GMOS) for the control of Salmonella 
infection in fattening pigs. 
 
Methods and Results 
Three different doses (0.5, 3 and 2 kg ß-GMOS per ton of feed) were used during the entire period of 
growing in 3 similar and independent field trials carried out in a small fattening unit (≈100 pigs). 
Treatment was randomly assigned to half of the pens. Individual serum samples (20-25 per group) 
were collected at different times during the fattening period and a similar number of fecal samples 
during the fattening period and at slaughter. In addition, mesenteric lymph nodes were collected at 
slaughter. Herdcheck® Swine Salmonella ELISA was used for serological analyses, the ISO 
6579:2002/Amd 1:2007 for bacteriology and the PFGE for molecular characterization of Salmonella 
strains. The addition of ≥2 kg t-1 of ß-GMOS to the pig diet during the entire fattening period was 
associated with a reduction of Salmonella prevalence, shedding and seroconversion. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Conclusions 
Feed supplementation with ß-GMOS may be a useful complementary tool for the control of 
salmonellosis in fattening pigs. 
 
Significance and Impact of the Study 
ß-GMOS may be a complementary way of reducing Salmonella shedding and infection in fattening 
pigs.    
 
Keywords: Salmonella, Control, Mannan oligosaccharides, Pigs, Food Safety, PFGE (pulsed field gel 
electrophoresis) 
 
Introduction 
In the European Union (EU) human salmonellosis is ranked as the second most important zoonoses 
transmitted through the consumption of food, after campylobacteriosis (EFSA 2014). This infection 
has been mostly associated with the consumption of Salmonella-contaminated poultry-derived 
products (eggs, meat, etc.) and in a less extent to other meat products such as pork or pork-derived 
products (EFSA, 2012). 
 
During the last years, the implementation in the EU of national eradication programs for Salmonella 
in poultry has caused a major decline in the incidence of the human salmonellosis related to poultry 
and products thereof throughout Europe (EFSA 2014), provoking a relative increase in the registered 
number of pork-related salmonellosis outbreaks, and emphasizing the need for programs to tackle this 
infection in pigs (Boyen et al. 2008). 
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Salmonella spp. are characterized by their ubiquity and great environmental resistance (Murray 2000), 
which favors the contact and further infection of domestic animals. Unlike Salmonella control 
programs in poultry, in pigs vaccines against zoonotic Salmonella are not commonly used yet (Farzan 
and Friendship 2010). Thus, given the problems associated with the identification of 
asymptomatically Salmonella-infected pigs, i.e. the lack of sensitivity of bacteriological and 
serological tests (Hurd et al. 2004; Mainar-Jaime et al. 2008a and 2008b; Vico et al. 2010), high 
standards on farm biosecurity and hygiene are of utmost importance to prevent the contact of this 
pathogen with the live pig (De Busser et al. 2013).  
 
The environmental contamination of the fattening unit is considered a major risk factor of Salmonella 
infection of slaughter pigs (Blaha 2010). Traditionally, the use of antibiotics at subtherapeutic doses, 
i.e. as growth promoters (AGP), has helped on the control of enteric diseases at critical periods of 
animal production such as weaning or the transition from nursery to fattening. However, the use of 
AGP also allowed for the development of antibiotic resistance (AR) (Witte 1998), which led to the 
ban of AGP use in Europe (Regulation EC No 1831/2003 on additives for use in animal nutrition). 
Indeed, the presence of resistant Salmonella has increased in recent years, and many human cases 
would be associated with the consumption of Salmonella-contaminated animal-derived foods (Arlet et 
al. 2006). Recent European reports show that AR is common in Salmonella isolates from human, 
animal and food samples (EFSA 2013). The increasing prevalence of AR in Salmonella strains 
highlights the need for the search of new alternatives to AGPs, such as probiotics and prebiotics 
(Gaggia et al. 2010).  
 
Mannan oligosaccharides (MOS) are non-digestible oligosaccharides that have been suggested as a 
potential alternative to AGPs (Davis et al. 2002; Castillo et al. 2008). Although MOS may exert a 
beneficial effect upon health and metabolism, their mode of action seems to differ to that from 
prebiotics as they do not selectively enrich for beneficial bacterial populations (Gaggia et al. 2010; 
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Halas and Nochta 2012). Besides, since they are not direct nutrients, they are considered as nutricines 
(Adams 2000). 
 
MOS would also have an additional important antimicrobial effect based on its capacity to bind to 
mannose-specific lectin of gram-negative pathogens that express Type-1 fimbriae (Borowsky et al. 
2009), thus blocking the adhesion of these bacteria to the enterocytes and preventing the subsequent 
colonization (Becker and Galletti 2008). This binding capacity may however be very variable because 
MOS come from a wide variety of sources (oil palm seeds, coffee beans, yeast, carob seeds, etc.), 
show a diverse biological composition, and are processed in very different ways (Spring 1999; Becker 
and Galletti 2008). Thus, each product should be well characterized and individually tested to 
determine its true efficacy for the control of pig salmonellosis. 
 
The effect of dietary MOS on Salmonella infection and/or shedding has been the subject of 
many studies in both poultry (Fernández et al. 2000; Spring et al. 2000) and pigs (Lettelier et 
al. 2000; White 2002; Burkey et al. 2004; Wenner 2013). Results either on animal 
performance or antimicrobial effect are often contradictory, likely due to the differences 
among products mentioned above and the dose used (Gaggia et al. 2010). In addition, the 
antimicrobial effect of dietary MOS in pigs have been mostly assessed through studies on 
weaning or nursery animals which may not have fully developed their immune system, for 
short periods of time (around four weeks) (Lettelier et al. 2000; Burkey et al. 2004; Castillo 
et al. 2008) and often after experimental infections that generally imply infective doses 
higher than that usually observed under natural environments (Calveyra et al. 2012). All 
these aspects may have contributed to the observation of inconsistent results. 
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The objective of the present study was to assess the efficacy of a novel β-galactomannan 
oligosaccharide (commercially available as Salmosan®, Industrial Técnica Pecuaria S.A., Barcelona, 
Spain) developed from the Mediterranean carob bean gum (Ceratonia siliqua) for the control of 
Salmonella spp. in fattening pigs. For this purpose, this MOS was administered to animals during the 
entire period of growing. In addition, the results from this study will allow us to get a better 
understanding of the epidemiology of Salmonella infection in fattening pigs. 
 
Materials and methods 
Experimental design 
The β-galactomannan oligosaccharide (ß-GMOS) used in these trials consisted of a β-(1–4)-mannose 
oligosaccharide backbone with branched galactose molecules (1:4 galactose/mannose ratio) (Warrand 
2006). Three different doses (0.5, 3 and 2 kg ß-GMOS per ton of feed) were used during the entire 
period of growing in 3 similar and independent field trials (I, II and III, respectively) carried out 
between 2010 and 2013 in a small commercial fattening unit (≈100 pigs) where Salmonella had been 
consistently isolated. The unit had eight pens which contained 12-13 pigs each. 
 
Treatment was randomly assigned to pigs allocated in half of the pens, thus pigs from four pens 
received the basal diet mixed with the corresponding dose of β-GMOS (treated group; TG) and pigs 
from the remaining four pens were fed with untreated basal diet (control groups; CG). Given the size 
of the fattening unit, the compound feed (with and without the β-GMOS) was provided in 40-kg bags 
and manually administered to the animals by the farmer throughout the entire period of fattening. The 
farmer was unaware of the treatment allocation. 
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Sampling scheme 
All pigs were given in-feed colistin (120 ppm) for around two weeks right after arriving to the farm 
unit. After colistin, the treatment with the β-GMOS was initiated in the TG and serum was collected 
from all animals from both groups to check for possible significant differences in seroprevalence 
against Salmonella spp. at the beginning of the trial. At 60 and 90 days of the fattening period 
individual serum was collected again from all animals and fecal samples (Faecal Samples at the Farm 
-FSF-) were collected after spontaneous defecation from 20-25 pigs per group. In each sampling, pig 
from all the pens were sampled, with a minimum of 2 pigs/pen. One week before slaughter serum was 
collected from a minimum of 40 pigs in each group (except in the first trial, where sera could not be 
collected for logistic reasons). Mesenteric lymph nodes (MLN) and feces from distal colon (Faecal 
Samples at the Slaughter -FSS-) were collected at slaughter (after approximately 120 days of 
fattening) for a similar number of pigs, except for the first trial where only MLN were collected. 
Because the inherent difficulties of collecting feces from rectum, slight variations in the number of 
sampled pigs with regard to the planned number of pigs to be sampled occurred. The exact number of 
animals analysed for each type of sample is shown in Tables 1 and 4.  
 
Bacteriology and strain characterization 
Bacteriology was performed on FSF, FSS and MLN samples following the standard International 
Organization for Standardization (ISO) 6579:2002/Amd 1:2007 method (ISO 2007). Serotyping was 
further carried out at the National Reference Laboratory for Animal Salmonellosis (Madrid, Spain) on 
one representative bacterial colony from culture-positive samples and following the White-Kauffman-
Le Minor scheme (Guibourdenche et al. 2010). 
 
In order to establish the relationship between Salmonella isolates from MLN and feces (either FSF or 
FSS) and thus assess the effect of the β-GMOS on both the infection and further shedding, Salmonella 
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strains showing the same serotype in both types of samples were further submitted to pulsed-field gel 
electrophoresis (PFGE). In addition, a representative number of strains of Salmonella serotypes 
showing the higher prevalence in this farm, i.e. Typhimurium, its monophasic variant 4,[5],12:i:-, and 
Rissen were also analyzed to assess their possible origin. Genotyping was performed according to the 
Pulse-Net protocol (Ribot et al. 2006). Details on the procedure followed are described elsewhere 
(Andrés et al. 2013). 
 
Antimicrobial resistance (AR) tests were also performed on isolates submitted to PFGE analyses in 
order to further characterize them. Susceptibility to a panel of 10 antimicrobials, i.e. ampicillin, 
chloramphenicol, streptomycin, sulfisoxazole, trimethoprim, tetracycline, gentamicin, nalidixic acid, 
ciprofloxacin and cefotaxime, was determined by the Kirby-Bauer disc diffusion method (Murray et 
al. 2007). Escherichia coli ATCC 25922 and both S. Typhimurium ATCC 14028 and DT104 
reference strains were used as controls. Salmonella strains were classified as resistant, intermediate or 
susceptible according to the Clinical and Laboratory Standard Institute recommendations (CLSI 
2012). In order to establish the multi-AR profiles, drugs were grouped into the following classes: 
aminopenicillins (A), phenicols (C), aminoglycosides (S), sulphonamides and dihydrofolate reductase 
inhibitors (Su), tetracyclines (T), cephalosporins (Cf) and quinolones (Na). 
 
Serology 
Collected sera were kept frozen (-20ºC) until serological analyses were carried out through the 
Herdcheck® Swine Salmonella ELISA (IDEXX Laboratories, Westbrook, Maine, USA). Analyses 
were performed following manufacturer’s instructions and different cut-off values (10%, 20% and 
40%) were considered. 
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Statistical analyses 
Univariable chi-squared analysis was used to assess statistical differences in seroprevalence and 
shedding between the CG and the TG at the different point times considered, and in prevalence at 
slaughter. When low values or zeros were present the two-tailed Fisher exact test was used (EPI INFO 
3.5.3., CDC, Atlanta, Georgia). A random-effects logistic regression (re-LG) with pen as the random 
factor was further performed to measure the overall effect that the use of the β-GMOS may have on 
the prevalence of infection and shedding at slaughter. The variable “Trial” was forced into the 
regression model as potential confounding factor (STATA/IC 12.1. StataCorp. LP, College Station, 
Texas). 
 
Results 
No relevant health-related problems were detected in any of the groups during the development of the 
field trials. Mortality rate was within the normal range (2-3%) for this farm for both groups for the 
three trials. No significant differences in seroprevalence were observed between the CG and the TG at 
the beginning of any of the three trials, thus groups were considered comparable. 
 
Bacteriological results  
The results on Salmonella spp. shedding (as indicated by fecal positive samples) and infection 
prevalence (MLN positive samples) for both the CG and the TG are presented in Table 1. The 
prevalence of Salmonella spp. infection in the CGs was above 40% in the three field trials, and 
significantly higher in trial II (78.7%) compared to trials I and III (54.8% and 40.8%, respectively; 
P<0.05). 
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In Trial I, where the lowest dose of the β-GMOS (0.5 kg t-1) was used, no significant differences were 
observed between TG and CG at any sampling time. However, at higher doses (2 and 3 kg t-1) both 
the prevalence of infection (i.e. proportion of pigs with Salmonella in MLN) and shedding at slaughter 
were significantly lower in the TG than in the CG. 
 
When the overall effect of the β-GMOS on Salmonella infection and shedding was estimated by the 
re-LG logistic regression using combined results from all the trials at slaughter, and after adjusting by 
trial and taking into account the pig allocation to pens (random factor), doses of 2 or 3 kg t-1 of β-
GMOS decreased significantly (P<0.01) the prevalence of infection and shedding (Table 2). A higher 
reduction was observed when a higher dose was used. 
  
Strain characterization  
Out of 198 strains of Salmonella isolated, only 149 (75%) were serotyped due to budget restrictions. 
All the non-serotyped strains corresponded to isolates from the CGs from trials II and III, as they were 
the groups presenting a larger number of isolates. At least 70% of the isolates from each of these two 
groups were serotyped (Table 3). 
 
Most (53%) of the serotyped isolates corresponded to the monophasic variant of Typhimurium 
(4,[5],12:i:-), followed by Typhimurium (17.4%), Rissen (16.8%), Goldcoast (6%) and other (6.7%) 
less prevalent serotypes. The distribution of strain serotypes by trial and type of sample is presented in 
Table 3. Interestingly, all 4,[5],12:i:- strains were detected in samples collected at the slaughterhouse 
(either from FSS or MLN) while Typhimurium and Rissen were detected at the farm and slaughter 
level. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
PFGE analyses were performed on isolates representing the three major serotypes (4,[5],12:i:-, 
Typhimurium and Rissen) as they were the only serotypes isolated from both fecal (either FSF or 
FSS) and MLN samples. A total of 19 isolates from trial I, 27 from trial II and 34 from trial III were 
analyzed (Figure 1). The PFGE analysis of these 80 Salmonella isolates showed 26 different XbaI 
patterns grouped into six main clusters with at least 90% of similarity. Overall, clusters matched well 
with serotypes and AR profiles. 
 
All strains showed resistance to at least two antimicrobial classes (Figure 1). AR to tetracycline was 
the most common (97.5%), followed by sulfisoxazole (95%), streptomycin (91.25%) and ampicillin 
(90%). A total of 10 multi-AR profiles were detected, being the most common ASSuT (n=42; 52.5%) 
generally associated to the 4,[5],12:i:- serotype, and ACSSuT (n=23; 28.75%) mostly associated to 
Typhimurium (Figure 1). 
 
Cluster 1 included mostly 4,[5],12:i:- strains from the three trials but also included three S. 
Typhimurium strains, two of them isolated from FSF. Cluster number 3 was composed by S. 
Typhimurium strains coming also from all the trials and from samples collected both at the farm and 
at the slaughter. Cluster number 6 consisted in 20 S. Rissen strains from the three trials and also 
collected both at the farm and at the slaughter. Clusters 2 (two strains), 4 (four strains) and 5 (one 
strain) were smaller clusters where all isolates belonged exclusively to trial III. When analyzed by 
trial, three main clusters were observed for trials I and II, and six for trial III. In all of them there were 
samples collected at the farm and at the slaughter within the same cluster. Considering the 90% 
similarity cut-off, the same strains of S. 4,[5],12:i:-, S. Typhimurium and S. Rissen were detected in 
all the trials (Figure 1). 
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An overall positive significant association between infection (i.e. Salmonella spp. isolated from MLN) 
and shedding was observed when all pigs from trials II and III were considered together. A carrier pig 
had >7 times higher risk of shedding Salmonella spp. than a non-carrier pig (Odds Ratio= 7.7; 95%CI: 
3.3-18.4; P<0.0001; results not shown). These results were supported by the observation in trial II of 
four control infected pigs shedding the same strain with which they were infected (three infected with 
S. 4,[5],12:i:- and one with S. Typhimurium), and in trial III with six S. 4,[5],12:i:- infected pigs 
shedding the same strain at slaughter (Figure 1). 
 
In addition, five pigs in trial II and two pigs in trial III shed at some point Salmonella strains different 
from those isolated from their MLN (Figure 1). 
 
Serology 
When the highest dose of the β-GMOS (3 kg t-1 feed) was used (trial II), a significant lower 
seroprevalence was observed in the TG compared to the CG at both 60 (P=0.005) and 90 days 
(P=0.06) in the fattening unit, and also before slaughter (P=0.004), when an OD≥40% was used as the 
cut-off value. No more differences in seroprevalence were observed at any time and at any cut-off for 
the other two trials (Table 4). Interestingly, in trial III, a slightly higher seroprevalence was observed 
for the TG at 90 days and previous to slaughter compared to the CG, but this difference was not 
statistically significant (P=0.12). 
 
Discussion  
In this study we looked at the effect of a dietary MOS, a β-GMOS characterized by a 1:4 
galactose/mannose ratio, when administered for the entire growing period on a small 
Salmonella-positive pig unit with low biosecurity level (i.e. no bird/rodent control, no 
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changing room, no footbaths or boots for visitors available, etc.). Under these field conditions 
we ensured the exposure of all pigs to the same naturally Salmonella-contaminated 
environment while half of them were also exposed to a constant concentration of the β-GMOS 
through the feed. Initially, a low dose (0.5 kg t-1 of feed) of β-GMOS was used as it had shown 
some antimicrobial effects in experimental studies on poultry (manufacturer personal 
communication). In this first trial, infection at MLN was the main outcome of interest and no 
fecal or serum samples were collected at slaughter. No significant effect was however 
observed on Salmonella infection at slaughter, neither on fecal shedding at the farm. These 
results could be explained by the large differences expected between poultry and pigs 
regarding intestinal physiology, amount of feed ingested, etc. In contrast, when the dose of β-
GMOS was considerably increased (trials II and III), a significant reduction in the proportion 
of Salmonella -infected (i.e. positive in MLN), -shedding and -seropositive (trial II) pigs at 
slaughter was observed in TGs respect to the corresponding CGs. In fact, the addition of ≥2 
kg t-1 of β-GMOS during the entire growing period was able to decrease the prevalence of 
Salmonella infection at slaughter to 0% in trial II and to less than 6% in trial III (Table 1). A 
similar finding was observed regarding Salmonella shedding at slaughter, which was reduced 
to 2.6% in trial II and to 11.8% in trial III (Table 1), while a significant reduction in 
seroconversion was only evidenced with the highest β-GMOS dose used (Table 4). 
 
At farm level, no differences in Salmonella shedding during the growing period were 
observed between the CG and the TG for any of the trials. However, factors such as the 
intermittent shedding of these bacteria over time (Pires et al. 2013), the lack of sensitivity of 
the microbiological technique when performed on fecal samples from asymptomatic pigs 
(Hurd et al. 2004; Mainar-Jaime et al. 2008a), and the limited number of animals analyzed in 
each group, may have hindered the detection of significant differences in shedding between 
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the CGs and TGs, at both 60 and 90 days of growing. At slaughter level, stress situations such 
as those associated with the transport of pigs to the slaughterhouse and with the lairage, may 
have favored the shedding of Salmonella from previously infected pigs (Hurd et al. 2001a; 
Boughton et al. 2007; Rostagno et al. 2011), which may have allowed for the detection of 
significant differences in the proportion of shedders between the CGs and TGs. The highly 
significant relationship observed between Salmonella-infected and Salmonella-shedder pigs 
would support this hypothesis. 
 
The results from the re-LG showed a clear decreasing trend in the prevalence of infection (i.e. 
Salmonella in MLN) at slaughter when the dose of β-GMOS increased from 2 to 3 kg t-1 of 
feed, in trials III and II, respectively. According to these results, the overall efficacy of β-
GMOS in these field trials, measured as the preventive fraction (1-Odds Ratio), could reach 
from 91% (when a 2 kg t-1  dose was used) up to 99.2% (3 kg t-1) when compared to the group 
composed by all control pigs from the trials. A similar decreasing trend would be expected on 
shedding, according to results shown in Table 2. Bearing in mind that the proportion of 
carrier pigs at slaughter could likely be considered a proxy of the Salmonella contamination 
arriving to the slaughter line (Berends et al. 1997), the addition of this β-GMOS may have 
contributed to decrease significantly the risk of Salmonella contamination of the carcasses. 
The PFGE analysis revealed that, within a trial, some strains of S. Typhimurium and S. 
Rissen that had been previously isolated from faeces at the farm were later found in MLN 
from control pigs at the slaughter (Figure 1), supporting this conclusion. It is worth to 
mention that a few pigs (5 in trial II and 2 in trial III) shed at some point Salmonella strains 
different from those isolated from their MLN (Figure 1), which would support the presence 
of simultaneous infections by different Salmonella strains in a single pig, as it has been 
recently described elsewhere (Garrido et al. 2014). 
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Interestingly, no S. 4,[5],12:i:- strains were isolated from fecal samples at the farm despite this 
serotype was the most prevalent in the three trials. This finding may be related to infections occurring 
outside the farm. In this regard, it has been observed that the truck and the lairage of a pig abattoir 
present a substantial risk for slaughter pigs to become infected with Salmonella (Swanenburg et al. 
2001; Dorr et al. 2009), and that S. Typhimurium may colonize enterocytes very rapidly (less than 2 
hours) after oral inoculation (Reed et al. 1986; Hurd et al. 2001b). Bearing in mind the average time 
spent by these pigs on the truck (1 hour) and waiting for slaughter (12 hours), either the truck or the 
lairage area may have acted as possible sources of infection for this serotype. Regardless where and 
when the exposure occurred, these results also suggest that the β-GMOS may have had an effect 
beyond the farm, reducing the risk of infection of the pigs even until right before the slaughter line. 
 
The positive effect of this β-GMOS on the control of Salmonella infection was further 
supported by the significant lower number of pigs seroconverting in the TG compared to the 
CG in trial II. In trial III, however, no differences were observed, as the proportion of pigs 
seroconverting was very low in both groups. This low level of seroconversion could be 
attributed to a late infection, either at the end of the fattening period, or even during transport 
to the slaughter or at lairage, as at least seven days are usually required to detect specific 
antibodies against Salmonella spp. (Nielsen et al. 1995; Scherer et al. 2008). In fact, 85% of 
the strains from this trial were isolated once the pigs arrived to the slaughter. The lack of 
seroconversion could also be related with the delayed onset of seroconversion showed by certain 
Salmonella strains that show higher faecal shedding and an increased persistence (Van Parys 
et al. 2013). The unexpected but non-significant difference in seroprevalence between CG 
and TG in this trial (0% vs. 7.8%, respectively) was most likely due to the intrinsic variability 
of the ELISA used, as three animals from the CG had high %ODs (>36%) but lower than the 
40% required to be deemed test negative. 
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A matter of concern derived from this study was the high level of AR observed. All 
Salmonella strains analyzed showed some type of multi AR. Since the origin of most isolates 
could not be traced to this farm, particularly the S. 4,[5],12:i:- strains, these results would 
reflect the overall increasing trend in AR for pig-related Salmonella strains. 
 
In view of the bacteriological results observed, this β-GMOS seemed to be effective against 
Salmonella infection in fattening pigs when a dose ≥2 kg t-1 of feed was used for the entire period of 
growing. Its use during the whole period of fattening was the consequence of the lack of knowledge 
regarding the time of higher risk of Salmonella exposure in this growing unit. A good knowledge of 
the dynamics of Salmonella infection in the farm may allow for the definition of the best periods of 
application, thus reducing its cost. Overall, feed supplementation with this β-GMOS could be 
considered a useful complementary tool for the control of pig salmonellosis, along with good hygiene 
and farm biosecurity practices.  
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Table 1. Microbiological results for Salmonella isolation (ISO 6579:2002/Amd 1:2007) for 
fecal samples at farm (FSF) after 60 (60d) and 90 (90d) days in the fattening unit and for 
mesenteric lymph nodes (MLN) and fecal samples at slaughter (FSS) for the three 
experimental groups of pigs. 
  Fattening unit Slaughter 
   FSF at 60d  FSF at 90d  MLN  FSS 
Tri
al* 
Gr
oup
†
 
 
No. (%) 
positives
‡
  
p§ 
 
No. (%) 
positives‡ 
p§ 
 
No. (%) 
positives‡ 
p§ 
 
No. (%) 
positives‡ 
p§ 
I 
CG 
 
4/19 (21) 0.
4
1 
 
1/20 (5) 0.
6
2 
 
23/42 
(54.8) 0.
24 
 
- 
- 
TG 
 
3/28 (10) 
 
3/27 (8.3)
 
19/45 
(42.2) 
 
- 
II 
CG 
 
3/25 (12) 0.
6
0 
 
2/25 (8) 0.
4
8 
 
37/47 
(78.7) 
<0
.0
1 
 
26/45 
(57.8) 
<
0.
0TG  1/25 (4)  0/25 (0)  0/39 (0)  1/39 
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(2.6) 1 
III 
CG 
 
7/26 
(26.9) 0.
1
5 
 
0/28 (0) 
1 
 
20/49 
(40.8) <0
.0
1 
 
34/49 
(69.4) 
<
0.
0
1 
TG 
 
2/23 
(8.7) 
 
1 (3.7) 
 
3/51 
(5.9) 
 
6/51 
(11.8) 
*Trial I: 0.5 kg ß-GMOS/t feed; Trial II: 3 kg ß-GMOS/t feed; Trial III: 2 kg ß-GMOS/t feed.  
†CG: control group; TG: treatment group. 
‡No. and percentage of Salmonella positive/total samples 
§
 Statistical significance (p values) between TG vs. CG groups 
 
 
Table 2. Results of the random-effect logistic regression* on the effect of a β-
galactomannan on Salmonella infection and shedding at slaughter.  
 Logistic regression parameters 
 Infection (MLN)† Shedding (Fecal samples)‡ 
Factor P OR 95%CI (OR) P OR 95%CI (OR) 
Doses       
  0 kg/t feed  1   1  
  0.5 kg/t feed 0.27 0.60 0.24, 1.50 - - - 
  2 kg/t feed <0.01 0.09 0.04, 0.18 <0.01 0.06 0.02, 0.13 
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  3 kg/t feed <0.01 0.007 0.001, 0.05 <0.01 0.019 0.002, 0.15 
       
Trial§       
  I   1  - - - 
  II  0.06 3.05 0.94, 9.88  1  
  III  0.21 0.57 0.23, 1.38 0.30 1.65 0.63, 4.32 
*Pen as random factor and trial as confounding factor. 
†An animal was artificially considered positive within the treatment group for Trial II to 
allow for model convergence.    
‡No fecal samples were collected for Trial I. 
§Trial I: 0.5 kg ß-GMOS/t feed; Trial II: 3 kg ß-GMOS/t feed; Trial III: 2 kg ß-GMOS/t 
feed. 
OR: Odds Ratio. 
95%CI: 95% Confidence Interval 
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Table 3. Distribution of Salmonella serotypes according to trial, group, and sample type. 
Trial* 
Group
†
 
Samp
le 
type‡ 
Serotypes 
   
Typhi-
muriu
m 
4,[5],12:
i:- 
Risse
n 
Goldcoa
st 
Other 
serotype
s§ 
non-
serotype
d 
TOTA
L 
I 
CG 
FSF 2  2  2  6 
FSS¶        
MLN 1 15 3 4   22 
TG 
FSF     4  4 
FSS1        
MLN 1 16  4   21 
II 
CG 
FSF 5      5 
FSS 7 4 4   11 26 
MLN 3 16 1 1  16 37 
TG 
FSF 1      1 
FSS   1    1 
MLN        
III CG FSF   8    8 
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FSS 3 14   3 14 34 
MLN 1 10 1   8 20 
TG 
FSF   4  1  5 
FSS 2 2 1    5 
MLN 1 2     3 
TOT
AL 
  26 79 25 9 10 49 198 
*Trial I: 0.5 kg ß-GMOS/t feed; Trial II: 3 kg ß-GMOS/t feed; Trial III: 2 kg ß-GMOS/t feed. 
†CG: control group; TG: treatment group.  
‡FSF: fecal samples at farm; FSS: Fecal samples at slaughter; MLN: Mesenteric lymph nodes.  
§Give (3), Kapemba (3), Derby (2), Muenchen (1), Brandenburg (1). 
¶Samples were not collected for Trial I. 
 
 
Table 4. Serological results (Herdcheck® Salmonella ELISA, cut-off %OD ≥40) for the three 
trials after 60 (60d) and 90 (90d) days in the fattening unit and before slaughter. 
  60 d 90d Before slaughter 
Trial* Group† N 
No. (%) 
positives‡  
p§ N 
No. (%) 
positives‡  
p§ N 
No. (%) 
positives‡  
p§ 
I¶ CG 55 3 (5.5) 0.98 55 4 (7.3) 0.46 - - - 
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TG 56 3 (5.4) 53 6 (11.3) - - - 
           
II 
CG 55 18 (32.7) 
<0.01 
53 13 (24.5) 
0.06 
40 15 (37.5) 
<0.01 
TG 56 6 (10.7) 55 6 (10.9) 40 4 (10) 
           
III 
CG 51 1 (1.9) 
1 
51 0 (0) 
0.12 
49 0 (0) 
0.12 
TG 51 2 (3.9) 50 3 (6) 51 4 (7.8) 
*Trial I: 0.5 kg ß-GMOS/t; Trial II: 3 kg ß-GMOS/t); Trial III: 2 kg ß-GMOS/t).  
†CG: control group; TG: treatment group. 
 
‡No. and percentage of Salmonella seropositive 
§
 Statistical significance (p values) between TG vs. CG groups 
¶No serum samples were collected for trial I before slaughter. 
 
 
Figure 1. Dendrogram showing the main XbaI patterns (>90% homology) for the S. Typhimurium, S. 
4,[5],12:i:- and S. Rissen strains isolated from the three trials carried out to assess the efficacy of 
different concentrations of a β-galactomannan oligosaccharide to control Salmonella infection in a 
fattening pig unit. 
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Figure 1 (continued). 
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